
Endoluminal radiofrequency ablation with SpyGlass� in the management of cholangiocarcinoma: a case report
Author(s) -
Rodrigo Mansilla-Vivar,
Lidia Argüello-Viúdez,
Cristina Sánchez-Montes,
Noelia Alonso-Lázaro,
Vicente Pons-Beltrán
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6230/2019
Subject(s) - medicine , radiofrequency ablation , palliative treatment , endoscopic stenting , radiology , general surgery , stent , ablation , surgery
Most extrahepatic cholangiocarcinomas are unresectable at the time of diagnosis and even in case of a resectable cancer, surgery is not an option for the elderly or patients with comorbidities (1). Current treatment alternatives in these scenarios are very limited. Biliary stenting with self-expanding metal stents (SEMS) is the mainstay palliative treatment for biliary obstruction (2). However, emerging experience with endoscopic RF ablation (RFA) in this setting has been reported in the literature.